MANILA, Philippines - A ranking official of the Catholic Bishops Conference of the Philippines (CBCP) considers immoral the embryonic stem cell therapy reportedly being used by politicians and actors for aesthetic purposes. In an interview with Radio Veritas, CBCP-Episcopal Commission on Bioethics Chairman and Malolos Bishop Jose Oliveros said this medical procedure is against the belief of the Church. He said they are still assessing if the same could be said for stem cells from animals. Pero yung sinasabi nila na pampabata sa mga politician at celebrities na sumailalim sa stem cell therapy ay immoral. Puwede namang ma-improve ang mukha ng isang tao, but it should be moral. Kapag gumamit ka ng immoral ay mali na yun, he said. Embryo is still a maturing fetus. He said the CBCP will come out with a pastoral statement regarding the matter once they are able to clarify certain matters with the Department of Health (DOH). The DOH earlier warned people from using stem cells from aborted babies and human embryos. The Philippine government will not allow the use of aborted fetuses or human embryosThere is a need to ensure that the biological raw materials are documented and validated and follow infection-free procedures, … Continue reading →

Public release date: 21-Nov-2012 [ | E-mail | Share ] Contact: Anne Grapin-Botton anne.grapin-botton@sund.ku.dk (45) 29-63-43-98 University of Copenhagen Scientists from The Danish Stem Cell Center (DanStem) at the University of Copenhagen are contributing important knowledge about how stem cells develop best into insulin-producing cells. In the long term this new knowledge can improve diabetes treatment with cell therapy. The results have just been published in the scientific journal Cell Reports. Stem cells are responsible for tissue growth and tissue repair after injury. Therefore, the discovery that these vital cells grow better in a three-dimensional environment is important for the future treatment of disease with stem cell therapy. "We can see that the quality of the cells produced two-dimensionally is not good enough. By putting the cells in a three-dimensional environment and giving them the proper growth conditions, we get much better results. Therefore we are developing a three-dimensional culture medium in gelatine in the laboratory to mimic the one inside an embryo," says Professor Anne Grapin-Botton from DanStem at the University of Copenhagen, who produced the results together with colleagues from Switzerland and Belgium. The international research team hopes that the new knowledge about three-dimensional cell growth environments can … Continue reading →

WEST HAVEN, Conn.--(BUSINESS WIRE)-- NanoViricides, Inc. (OTC: NNVC) (the "Company"), has filed its quarterly report with the Securities and Exchange Commission yesterday, November 19th, in a timely fashion. The submission can be downloaded from the SEC website at http://www.sec.gov/Archives/edgar/data/1379006/000114420412063924/0001144204-12-063924-index.htm. The Company reported that it had approximately $12.930M in cash and cash equivalents, and approximately $438,000 in prepaid expenses as of September 30, 2012, the end of the reporting quarter. The shareholder equity stood at approximately $12.796M. In comparison, the Company had approximately $14.275M in cash and cash equivalents, approximately $314,000 in prepaid expenses, and $13.850M in shareholder equity as of June 30, 2012. The Company spent approximately $1.210M in Research and Development expenses (R&D) and approximately $381,000 in General and Administrative expenses (G&A) in the reported quarter. The Companys rate of expenditure was in line with the Companys budgeted targets. The Company has been successful in raising additional capital as needed. The Company estimates that it currently has sufficient cash in hand to support operations for at least two years from reported period at the current rate of cash expenditure. The Company has neither any long term debt, nor any short term debt, other than working capital accounts payables. The … Continue reading →

A new nanoparticle could improve chemotherapy treatment for a deadly form of cancer that attacks children. Neuroblastoma is a cancer that requires aggressive chemotherapy that can leave patients with lingering health problems, so any way to reduce the amount of chemotherapy drugs given would be welcome, say researchers from the Australian Center for Nanomedicine at the University of New South Wales in Sydney. Immortality for Humans by 2045 The UNSW team made a nanometer-sized particle that delivers nitric oxide (NO) to the tumor cells. The nitric oxide particles are injected directly into the tumor, which kills the cancer cells. So far, it has been tested in the lab, on cultured neuroblastoma cells. The work was reported in the journal Chemical Communications. D Cyrille Boyer from the School of Chemical Engineering, one of the co-authors of the study, told Discovery News that each particle is less than 20 nanometers across, and is made of a polymer coated with a molecule that binds to the target cell. Once the tiny particle is inside the cell, it dissolves and releases the nitric oxide. The idea was to make a particle a capsule that is stable when exposed to blood serum, for example, but … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/xm4z3j/lipids_in) has announced the addition of AOCS Press's new book "Lipids in Nanotechnology" to their offering. Nanotechnology is a rapidly expanding field which includes fundamental nanoscale phenomena and processes, nanomaterials, nanoscale devices and systems, nanomanufacturing, and benefits and risks of nanotechnology. This book serves as a valuable reference and resource for those interested in the field of nanotechnology - from basic research to engineering aspects of nanoparticles. It covers thermodynamics to engineering aspects of nanoparticles or nanoemulsions; synthesis and applications of surface active lipids to food and cosmetics; and pharmaceutical applications to nanomedicine. Lipids in Nanotechnology will be useful to scholars, scientists, and technologists who are interested in the field of lipid nanotechnology. Key Topics Covered: Nanotechnology: Emerging Interest, Opportunities, and Challenges Surface Active Lipids as Encapsulation Agents and Delivery Vehicles Milk Phospholipids: A Nanocarrier System for Delivery of Bioactive Compounds Marine Phospholipid Liposomes Formulation of Lipid Micro/Nanodispersion Systems Read the original here: Research and Markets: Lipids in Nanotechnology … Continue reading →

Researchers from UNSWs Australian Centre for Nanomedicine have developed a nanoparticle that improves the effectiveness of chemotherapy for neuroblastoma by a factor of five. Neuroblastoma is an aggressive childhood cancer that often leaves survivors with lingering health problems due to the high doses of chemotherapy required for treatment. Anything that can reduce these doses is considered an important development. The UNSW researchers developed a non-toxic nanoparticle that can deliver and release nitric oxide (NO) to specific cancer cells in the body. The findings of their in vitro experiments have been published in the journal Chemical Communications. When we injected the chemo drug into the neuroblastoma cells that had been pre-treated with our new nitric oxide nanoparticle we needed only one-fifth the dose, says co-author Dr Cyrille Boyer from the School of Chemical Engineering at UNSW. By increasing the effectiveness of these chemotherapy drugs by a factor of five, we can significantly decrease the detrimental side-effects to healthy cells and surrounding tissue. This synergistic effect between nitric oxide and chemotherapy drugs had previously been reported in other cancer cell lines, but the delivery compounds were potentially toxic and had very poor stability, or shelf life. In contrast, the UNSW-developed nanoparticle is … Continue reading →

Public release date: 20-Nov-2012 [ | E-mail | Share ] Contact: Steve Offner s.offner@unsw.edu.au 61-293-851-583 University of New South Wales In a world-first, researchers from the Australian Centre for Nanomedicine at the University of New South Wales (UNSW) in Sydney have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five. Neuroblastoma is an aggressive childhood cancer that often leaves survivors with lingering health problems due to the high doses of chemotherapy drugs required for treatment. Anything that can potentially reduce these doses is considered an important development. The UNSW researchers developed a non-toxic nanoparticle that can deliver and release nitric oxide (NO) to specific cancer cells in the body. The findings of their in vitro experiments have been published in the journal Chemical Communications. "When we injected the chemo drug into the neuroblastoma cells that had been pre-treated with our new nitric oxide nanoparticle we needed only one-fifth the dose," says co-author Dr Cyrille Boyer from the School of Chemical Engineering at UNSW. "By increasing the effectiveness of these chemotherapy drugs by a factor of five, we could significantly decrease the detrimental side-effects to healthy cells and surrounding tissue." This synergistic effect … Continue reading →

cord blood registry | The Development of Umbilical Cord Blood Stem Cell Therapy http://www.cordbloodrecommendation.com These diseases include blood related, genetic and neurotic disorders. ""Banking the umbilical cord blood when your baby is born is a relatively new idea, the first operation using it to help cure a child with Leukemia was only done a little over 10 years ago. After processing of cells, comes the next procedure of cord blood preservation. There is also another option given by non-profit cord blood banks, of free programs through which one can store umbilical cord blood stem cell samples. A man can change his god-gifted features wishfully with the help of science. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. With people not fully understanding how important stem cells could be for us, everybody agrees that more research need to be done in order to help understand all that. If there is any complication during … Continue reading →

Stem cells achieve sustained heart function improvement in heart attack patients From Louisville - Stem cell therapy has been shown to sustain heart function improvement in heart attack patients in a phase 1 clinical presented at the AHA's Scientific Sessions. The trial, known as SCIPIO for Stem Cell Infusion in Patients with Ischemic CardiOmyopathy, randomized 33 patients diagnosed with heart failure after suffering a heart attack to either cardiac stem cells or no stem cells. Researchers found that patients who received the stem cells had great improvement in their heart function, and that this improvement was sustained 2 years following infusion. Patients who did not receive stem cells had no improvement. There were no adverse effects of the treatment. One patient's heart experienced such dramatic improvement that there was no sign of heart failure at all. Said Dr. Roberto Bolli, lead author of the study, "Anyone who looks at his heart now would not imagine that this patient was (ever) in heart failure or that he had a heart attack."From:insidermedicineViews:0 0ratingsTime:00:59More inScience Technology Excerpt from: Stem cells achieve sustained heart function improvement in heart attack patients - Video … Continue reading →

24K Gold Get the best offer here redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fdp%2FB0079QOQRG Product Description 24K Gold Experience the Anti-Aging Power of the New Generation 24K Nano Gold Stem Cell Therapy Mask. This excellent product by BeautyMedica Lab offers an innovative Transdermal Delivery System with a unique blend of transforming growth factors (TGF), amino acids, antioxidants and peptides.Sheet form of the mask makes it extremely easy to apply to the face and allowing the ingredients to be absorbed into the skin slowly melting under body temperature. The Mask was formulated to Re-activate stem cells and stimulate new skin development. Increase collagen production and elastin synthesis. Minimize appearance of fine lines and wrinkles. Enhance moisture with Y-PGA and refine skin structure. Whiten the skin and reduce melanin. Restore youthful healthy looking skin and creates radiant skin appearance.For more info, please visit 24K Gold Mask presentation video by Beauty Medical Laboratorys - http://www.youtube.comFrom:Bernarda YooViews:0 0ratingsTime:00:58More inScience Technology See the rest here: 24K Gold - Video … Continue reading →